[시장보고서]성장인자 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

성장인자 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Growth Factors Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

상품코드 : 1618995

리서치사 : Persistence Market Research

발행일 : 2024년 12월

페이지 정보 : 영문 194 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,229,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,558,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,295,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

주요 인사이트

2024년 성장인자 시장 규모(2024년) : 22억 달러
시장 규모 예측(2031년) : 33억 달러
세계 시장 성장률(2024-2031년) : CAGR 5.8%

시장 촉진요인:

성장인자 시장은 주로 암, 당뇨병과 같은 만성질환의 유병률 증가로 인해 첨단 치료 솔루션이 필요한 상황에서 성장인자 시장이 주도하고 있습니다. 성장인자는 표적 치료와 재생 의학에서 매우 중요한 역할을 하고 있으며, 조직 공학 및 상처 치유에 대한 적용을 더욱 촉진하고 있습니다. 생명공학 분야의 기술 발전은 재조합 성장인자의 생산에 혁명을 일으켜 접근성과 효능을 향상시키고 있습니다. 또한, 전 세계적으로 고령화가 진행되면서 혁신적인 치료법에 대한 수요가 급증하고 있습니다. 또한, 맞춤형 의료의 발전은 정밀 치료에서 성장인자의 잠재력을 높이고 있습니다.

시장 억제요인:

좋은 성장 전망에도 불구하고, 세계 성장인자 시장은 몇 가지 도전에 직면해 있습니다. 재조합 성장인자의 생산 및 상업화에 따른 높은 비용은 특히 비용에 민감한 시장에서 그 보급을 저해할 수 있습니다. 규제 장벽과 까다로운 승인 절차는 제품 출시를 지연시키고 시장 성장에 영향을 미칠 수 있습니다. 또한, 신흥국 시장에서는 성장인자의 치료적 적용에 대한 인식이 낮고, 대체 치료법과의 경쟁은 시장 성장에 또 다른 도전이 될 수 있습니다.

시장 기회:

재생의료 및 만성질환 관리 분야에서 성장인자의 새로운 용도 개발은 큰 성장 기회를 가지고 있습니다. 종양 및 맞춤의료와 같은 신흥 분야로 성장인자를 확대하는 것은 기술 혁신의 새로운 길을 열어줄 것입니다. 생명공학 기업, 연구기관, 의료 서비스 제공자 간의 협력적 노력은 이 분야의 발전을 가속화할 것으로 예상됩니다. 또한, 정밀의료의 도입은 특히 의료 인프라가 발달한 선진 지역에서 큰 시장 개척 가능성을 가지고 있습니다. 의료 투자 확대에 힘입은 신흥국의 미개척 시장은 또 다른 유망한 성장 분야로 꼽힙니다.

세계 성장인자 시장을 조사했으며, 시장의 정의와 개요, 시장 촉진·억제요인, 각종 동향, 시장 기회와 과제, 시장 규모(금액 및 일부 수량) 추이와 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

주요 하이라이트
- 시장 규모·전년비 성장률
- 수익 기회
시장 규모 분석과 예측
세계 시장 전망 : 제품별
세계 시장 전망 : 등급별
세계 시장 전망 : 용도별
세계 시장 전망 : 발현 호스트 시스템별
세계 시장 전망 : 작용기전별
세계 시장 전망 : 유래 종별
세계 시장 전망 : 최종사용자별

제5장 세계의 성장인자 시장 전망 : 지역별

주요 하이라이트
시장 규모 추정
시장 규모 예측
- 북미
- 유럽
- 동아시아
- 남아시아 및 오세아니아
- 라틴아메리카
- 중동 및 아프리카
시장 매력 분석 : 지역

제6장 북미의 성장인자 시장 전망 : 추이와 예측

주요 하이라이트
시장 규모 추정
- 국가별
- 제품별
- 등급별
- 용도별
- 발현 호스트 시스템별
- 작용기전별
- 유래 종별
- 최종사용자별
시장 규모 추정과 예측 : 국가별
- 미국
- 캐나다
시장 규모 추정과 예측 : 제품별
- 전환성장인자(TGF)
- 표피성장인자(EGF)
- 혈소판 유래 성장인자(PDGF)
- 섬유아세포 증식인자(FGF)
- 인슐린 유사 성장인자(IGF)
- 혈관내피성장인자(VEGF)
- 간세포 증식인자(HGF)
- 종양괴사인자(TNF)
- 인터류킨
- 기타
시장 규모 추정과 예측 : 등급별
- GMP 등급
- 비GMP 등급
시장 규모 추정과 예측 : 용도별
- 종양
- 혈액
- 상처 치유
- 피부과
- 심혈관질환·당뇨병
- 세포 치료·체외 제조
- 기타
시장 규모 추정과 예측 : 발현 호스트 시스템별
- 동물 유래 성장인자
- 재조합 성장인자
시장 규모 추정과 예측 : 작용기전별
- 혈관신생 성장인자
- 항 아포토시스 성장인자
- 분열 촉진 성장인자
시장 규모 추정과 예측 : 유래 종별
- 인간
- 돼지
- 마우스
- 래트
- 기타
시장 규모 추정과 예측 : 최종사용자별
- 제약·바이오테크놀러지 기업
- 연구 센터·학술기관
- CRO
시장 매력 분석

제7장 유럽의 성장인자 시장 전망 : 추이와 예측

주요 하이라이트
시장 규모 추정
시장 규모 추정과 예측 : 국가별
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 터키
- 기타
시장 규모 추정과 예측 : 제품별
시장 규모 추정과 예측 : 등급별
시장 규모 추정과 예측 : 용도별
시장 규모 추정과 예측 : 발현 호스트 시스템별
시장 규모 추정과 예측 : 작용기전별
시장 규모 추정과 예측 : 유래 종별
시장 규모 추정과 예측 : 최종사용자별
시장 매력 분석

제8장 동아시아의 성장인자 시장 전망 : 추이와 예측

주요 하이라이트
시장 규모 추정
시장 규모 추정과 예측 : 국가별
- 중국
- 일본
- 한국
시장 규모 추정과 예측 : 제품별
시장 규모 추정과 예측 : 등급별
시장 규모 추정과 예측 : 용도별
시장 규모 추정과 예측 : 발현 호스트 시스템별
시장 규모 추정과 예측 : 작용기전별
시장 규모 추정과 예측 : 유래 종별
시장 규모 추정과 예측 : 최종사용자별
시장 매력 분석

제9장 남아시아 및 오세아니아의 성장인자 시장 전망 : 추이와 예측

주요 하이라이트
시장 규모 추정
시장 규모 추정과 예측 : 국가별
- 인도
- 동남아시아
- 호주
- 기타
시장 규모 추정과 예측 : 제품별
시장 규모 추정과 예측 : 등급별
시장 규모 추정과 예측 : 용도별
시장 규모 추정과 예측 : 발현 호스트 시스템별
시장 규모 추정과 예측 : 작용기전별
시장 규모 추정과 예측 : 유래 종별
시장 규모 추정과 예측 : 최종사용자별
시장 매력 분석

제10장 라틴아메리카의 성장인자 시장 전망 : 추이와 예측

주요 하이라이트
시장 규모 추정
시장 규모 추정과 예측 : 국가별
- 브라질
- 멕시코
- 기타
시장 규모 추정과 예측 : 제품별
시장 규모 추정과 예측 : 등급별
시장 규모 추정과 예측 : 용도별
시장 규모 추정과 예측 : 발현 호스트 시스템별
시장 규모 추정과 예측 : 작용기전별
시장 규모 추정과 예측 : 유래 종별
시장 규모 추정과 예측 : 최종사용자별
시장 매력 분석

제11장 중동 및 아프리카의 성장인자 시장 전망 : 추이와 예측

주요 하이라이트
시장 규모 추정
시장 규모 추정과 예측 : 국가별
- GCC 국가
- 이집트
- 남아프리카공화국
- 북아프리카
- 기타
시장 규모 추정과 예측 : 제품별
시장 규모 추정과 예측 : 등급별
시장 규모 추정과 예측 : 용도별
시장 규모 추정과 예측 : 발현 호스트 시스템별
시장 규모 추정과 예측 : 작용기전별
시장 규모 추정과 예측 : 유래 종별
시장 규모 추정과 예측 : 최종사용자별
시장 매력 분석

제12장 경쟁 구도

시장 점유율 분석
시장 구조
기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Lonza Group AG
- F. Hoffmann-La Roche Ltd.
- Sartorius CellGenix GmbH
- Bio-Techne Corporation
- GenScript
- Miltenyi Biotec.
- Abcam PLC
- Sino Biological Inc.
- Cell Signaling Technology, Inc.
- ACROBiosystems
- Becton, Dickinson, and Company
- Creative Bioarray
- Applied Biological Materials(abm) Inc.
- GE Healthcare
- Meridian Bioscience Inc.
- Repligen Corporation
- Aviva Systems Biology Corporation(GenWay Biotech)
- Leadgene Biomedical, Inc.
- Boster Bio
- Prospec-Tany Technogene Ltd.
- Proteintech Group, Inc.
- AJINOMOTO CO.,INC
- STEMCELL Technologies
- Akron Biotech
- PeproTech Inc.

제13장 부록

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Growth Factors Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions

Key Insights:

Growth Factors Market Size (2024E): US$ 2.2 Bn
Projected Market Value (2031F): US$ 3.3 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 5.8%

Growth Factors Market - Report Scope:

The global growth factors market comprises biologically active proteins or peptides that play essential roles in cell proliferation, differentiation, and tissue regeneration. These compounds are increasingly being used in regenerative medicine, oncology, and chronic disease management. The market's growth trajectory is influenced by innovations in biotechnology, enabling the production of recombinant growth factors with enhanced efficacy and scalability. The market also benefits from supportive government initiatives, rising investments in biomedical research, and the increasing prevalence of chronic diseases worldwide.

Market Drivers:

The growth factors market is primarily driven by the rising prevalence of chronic diseases such as cancer and diabetes, necessitating advanced therapeutic solutions. Growth factors play a pivotal role in targeted therapies and regenerative medicine, further driving their adoption in tissue engineering and wound healing applications. Technological advancements in biotechnology have revolutionized the production of recombinant growth factors, enhancing their accessibility and effectiveness. Additionally, the global aging population is creating a surge in demand for innovative therapeutic approaches. Government initiatives and increased funding for biomedical research provide further impetus to the market, while advancements in personalized medicine amplify the potential of growth factors in precision therapies.

Market Restraints:

Despite the favorable growth prospects, the global growth factors market faces several challenges. The high costs associated with the production and commercialization of recombinant growth factors can hinder their widespread adoption, particularly in cost-sensitive markets. Regulatory hurdles and stringent approval processes can delay product launches, impacting market growth. Furthermore, limited awareness about the therapeutic applications of growth factors in developing regions and competition from alternative treatment modalities pose additional challenges for the market.

Market Opportunities:

Significant growth opportunities exist in the development of novel applications for growth factors in regenerative medicine and chronic disease management. The expansion of growth factors into emerging fields such as oncology and personalized medicine opens up new avenues for innovation. Collaborative efforts between biotechnology firms, research institutions, and healthcare providers are expected to accelerate advancements in this domain. Moreover, the increasing adoption of precision medicine presents substantial market potential, particularly in developed regions with advanced healthcare infrastructure. Untapped markets in emerging economies, supported by growing healthcare investments, represent another promising growth area for the market.

Key Questions Answered in the Report:

What are the primary factors driving the global growth of the growth factors market?
Which therapeutic areas are gaining the highest adoption across different regions?
How are advancements in biotechnology shaping the competitive landscape of the growth factors market?
Who are the key players in the growth factors market, and what strategies are they employing to maintain their market positions?
What are the emerging trends and future outlooks for the global growth factors market?

Competitive Intelligence and Business Strategy:

Leading companies in the global growth factors market, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, and Lonza Group AG, are focusing on innovations in biotechnology to maintain their competitive edge. These players are leveraging advancements in recombinant technology to develop highly efficacious growth factors for targeted therapies and regenerative applications. Partnerships between pharmaceutical companies and academic research institutions are driving research and accelerating commercialization timelines. Companies are also emphasizing affordability and accessibility to cater to a broader patient population while aligning with global healthcare goals.

Key Companies Profiled:

Thermo Fisher Scientific, Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Lonza Group AG
F. Hoffmann-La Roche Ltd.
Sartorius CellGenix GmbH
Bio-Techne Corporation
GenScript
Miltenyi Biotec.
Abcam PLC
Sino Biological Inc.
Cell Signaling Technology, Inc.
ACROBiosystems
Becton, Dickinson, and Company
Creative Bioarray
Applied Biological Materials (abm) Inc.
GE Healthcare
Meridian Bioscience Inc.
Repligen Corporation
Aviva Systems Biology Corporation (GenWay Biotech)
Leadgene Biomedical, Inc.
Boster Bio
Prospec-Tany Technogene Ltd.
Proteintech Group, Inc.
AJINOMOTO CO., Inc.
STEMCELL Technologies
Akron Biotech
PeproTech Inc.

Growth Factors Market Segmentation:

By Product

Transforming Growth Factors (TGF)
Epidermal Growth Factors (EGFs)
Platelet-derived Growth Factors (PDGFs)
Fibroblast Growth Factors (FGFs)
Insulin-like Growth Factors (IGFs)
Vascular Endothelial Growth Factors (VEGFs)
Hepatocyte Growth Factors (HGFs)
Tumor Necrosis Factors (TNFs)
Interleukins
Others

By Grade

GMP Grade
NON-GMP Grade

By Application

Oncology
Hematology
Wound Healing
Dermatology
Cardiovascular Disease and Diabetes
Cell Therapy and EX-vivo Manufacturing
Others

By Expression Host System

Animal-derived
Recombinant

By Mode of Action

Angiogenic
Anti-apoptotic
Mitogenic

By Species Origin

Human
Pig
Mouse
Rat
Others

By End User

Pharmaceutical and Biotechnology Companies
Research Centers and Academic Institutes
Contract Research Organizations

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

1. Executive Summary

1.1. Global Growth Factors Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis

4. Global Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
- 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
4.3. Global Growth Factors Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019 - 2023
- 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
  - 4.3.3.1. Transforming Growth Factors (TGF)
    - 4.3.3.1.1. Activin
    - 4.3.3.1.2. Bone Morphogenetic Proteins (BMPs)
    - 4.3.3.1.3. TGF-beta Proteins
  - 4.3.3.2. Epidermal Growth Factors (EGFs)
  - 4.3.3.3. Platelet-Derived Growth Factors (PDGFs)
  - 4.3.3.4. Fibroblast Growth Factors (FGFs)
  - 4.3.3.5. Insulin-like Growth Factors (IGFs)
  - 4.3.3.6. Vascular Endothelial Growth Factors (VEGFs)
  - 4.3.3.7. Hepatocyte Growth Factors (HGFs)
  - 4.3.3.8. Tumor Necrosis Factors (TNFs)
  - 4.3.3.9. Interleukins
  - 4.3.3.10. Others
- 4.3.4. Market Attractiveness Analysis: Product
4.4. Global Growth Factors Market Outlook: Grade
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Grade, 2019 - 2023
- 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
  - 4.4.3.1. GMP Grade
  - 4.4.3.2. NON-GMP Grade
- 4.4.4. Market Attractiveness Analysis: Grade
4.5. Global Growth Factors Market Outlook: Application
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
- 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
  - 4.5.3.1. Oncology
  - 4.5.3.2. Hematology
  - 4.5.3.3. Wound Healing
  - 4.5.3.4. Dermatology
  - 4.5.3.5. Cardiovascular Disease & Diabetes
  - 4.5.3.6. Cell Therapy & EX-vivo Manufacturing
  - 4.5.3.7. Others
- 4.5.4. Market Attractiveness Analysis: Application
4.6. Global Growth Factors Market Outlook: Expression Host System
- 4.6.1. Introduction / Key Findings
- 4.6.2. Historical Market Size (US$ Bn) Analysis, By Expression Host System, 2019 - 2023
- 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
  - 4.6.3.1. Animal Derived
  - 4.6.3.2. Recombinant
- 4.6.4. Market Attractiveness Analysis: Expression Host System
4.7. Global Growth Factors Market Outlook: Mode of Action
- 4.7.1. Introduction / Key Findings
- 4.7.2. Historical Market Size (US$ Bn) Analysis, By Mode of Action, 2019 - 2023
- 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
  - 4.7.3.1. Angiogenic
  - 4.7.3.2. Anti-apoptotic
  - 4.7.3.3. Mitogenic
- 4.7.4. Market Attractiveness Analysis: Mode of Action
4.8. Global Growth Factors Market Outlook: Species Origin
- 4.8.1. Introduction / Key Findings
- 4.8.2. Historical Market Size (US$ Bn) Analysis, By Species Origin, 2019 - 2023
- 4.8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
  - 4.8.3.1. Human
  - 4.8.3.2. Pig
  - 4.8.3.3. Mouse
  - 4.8.3.4. Rat
  - 4.8.3.5. Others
- 4.8.4. Market Attractiveness Analysis: Species Origin
4.9. Global Growth Factors Market Outlook: End User
- 4.9.1. Introduction / Key Findings
- 4.9.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
- 4.9.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
  - 4.9.3.1. Pharmaceutical and Biotechnology Companies
  - 4.9.3.2. Research Centers & Academic Institutes
  - 4.9.3.3. Contract Research Organizations
- 4.9.4. Market Attractiveness Analysis: End User

5. Global Growth Factors Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 6.2.1. By Country
- 6.2.2. By Product
- 6.2.3. By Grade
- 6.2.4. By Application
- 6.2.5. By Expression Host System
- 6.2.6. By Mode of Action
- 6.2.7. By Species Origin
- 6.2.8. By End User
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
- 6.4.1. Transforming Growth Factors (TGF)
  - 6.4.1.1. Activin
  - 6.4.1.2. Bone Morphogenetic Proteins (BMPs)
  - 6.4.1.3. TGF-beta Proteins
- 6.4.2. Epidermal Growth Factors (EGFs)
- 6.4.3. Platelet-Derived Growth Factors (PDGFs)
- 6.4.4. Fibroblast Growth Factors (FGFs)
- 6.4.5. Insulin-like Growth Factors (IGFs)
- 6.4.6. Vascular Endothelial Growth Factors (VEGFs)
- 6.4.7. Hepatocyte Growth Factors (HGFs)
- 6.4.8. Tumor Necrosis Factors (TNFs)
- 6.4.9. Interleukins
- 6.4.10. Others
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
- 6.5.1. GMP Grade
- 6.5.2. NON-GMP Grade
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 6.6.1. Oncology
- 6.6.2. Hematology
- 6.6.3. Wound Healing
- 6.6.4. Dermatology
- 6.6.5. Cardiovascular Disease & Diabetes
- 6.6.6. Cell Therapy & EX-vivo Manufacturing
- 6.6.7. Others
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
- 6.7.1. Animal-Derived Growth Factors
- 6.7.2. Recombinant Growth Factors
6.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
- 6.8.1. Angiogenic Growth Factors
- 6.8.2. Anti-Apoptotic Growth Factors
- 6.8.3. Mitogenic Growth Factors
6.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
- 6.9.1. Human
- 6.9.2. Pig
- 6.9.3. Mouse
- 6.9.4. Rat
- 6.9.5. Others
6.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 6.10.1. Pharmaceutical and Biotechnology Companies
- 6.10.2. Research Centers & Academic Institutes
- 6.10.3. Contract Research Organizations
6.11. Market Attractiveness Analysis

7. Europe Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Grade
- 7.2.4. By Application
- 7.2.5. By Expression Host System
- 7.2.6. By Mode of Action
- 7.2.7. By Species Origin
- 7.2.8. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
- 7.4.1. Transforming Growth Factors (TGF)
  - 7.4.1.1. Activin
  - 7.4.1.2. Bone Morphogenetic Proteins (BMPs)
  - 7.4.1.3. TGF-beta Proteins
- 7.4.2. Epidermal Growth Factors (EGFs)
- 7.4.3. Platelet-Derived Growth Factors (PDGFs)
- 7.4.4. Fibroblast Growth Factors (FGFs)
- 7.4.5. Insulin-like Growth Factors (IGFs)
- 7.4.6. Vascular Endothelial Growth Factors (VEGFs)
- 7.4.7. Hepatocyte Growth Factors (HGFs)
- 7.4.8. Tumor Necrosis Factors (TNFs)
- 7.4.9. Interleukins
- 7.4.10. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
- 7.5.1. GMP Grade
- 7.5.2. NON-GMP Grade
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 7.6.1. Oncology
- 7.6.2. Hematology
- 7.6.3. Wound Healing
- 7.6.4. Dermatology
- 7.6.5. Cardiovascular Disease & Diabetes
- 7.6.6. Cell Therapy & EX-vivo Manufacturing
- 7.6.7. Others
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
- 7.7.1. Animal-Derived Growth Factors
- 7.7.2. Recombinant Growth Factors
7.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
- 7.8.1. Angiogenic Growth Factors
- 7.8.2. Anti-Apoptotic Growth Factors
- 7.8.3. Mitogenic Growth Factors
7.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
- 7.9.1. Human
- 7.9.2. Pig
- 7.9.3. Mouse
- 7.9.4. Rat
- 7.9.5. Others
7.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 7.10.1. Pharmaceutical and Biotechnology Companies
- 7.10.2. Research Centers & Academic Institutes
- 7.10.3. Contract Research Organizations
7.11. Market Attractiveness Analysis

8. East Asia Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Grade
- 8.2.4. By Application
- 8.2.5. By Expression Host System
- 8.2.6. By Mode of Action
- 8.2.7. By Species Origin
- 8.2.8. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
- 8.4.1. Transforming Growth Factors (TGF)
  - 8.4.1.1. Activin
  - 8.4.1.2. Bone Morphogenetic Proteins (BMPs)
  - 8.4.1.3. TGF-beta Proteins
- 8.4.2. Epidermal Growth Factors (EGFs)
- 8.4.3. Platelet-Derived Growth Factors (PDGFs)
- 8.4.4. Fibroblast Growth Factors (FGFs)
- 8.4.5. Insulin-like Growth Factors (IGFs)
- 8.4.6. Vascular Endothelial Growth Factors (VEGFs)
- 8.4.7. Hepatocyte Growth Factors (HGFs)
- 8.4.8. Tumor Necrosis Factors (TNFs)
- 8.4.9. Interleukins
- 8.4.10. Others
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
- 8.5.1. GMP Grade
- 8.5.2. NON-GMP Grade
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 8.6.1. Oncology
- 8.6.2. Hematology
- 8.6.3. Wound Healing
- 8.6.4. Dermatology
- 8.6.5. Cardiovascular Disease & Diabetes
- 8.6.6. Cell Therapy & EX-vivo Manufacturing
- 8.6.7. Others
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
- 8.7.1. Animal-Derived Growth Factors
- 8.7.2. Recombinant Growth Factors
8.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
- 8.8.1. Angiogenic Growth Factors
- 8.8.2. Anti-Apoptotic Growth Factors
- 8.8.3. Mitogenic Growth Factors
8.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
- 8.9.1. Human
- 8.9.2. Pig
- 8.9.3. Mouse
- 8.9.4. Rat
- 8.9.5. Others
8.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 8.10.1. Pharmaceutical and Biotechnology Companies
- 8.10.2. Research Centers & Academic Institutes
- 8.10.3. Contract Research Organizations
8.11. Market Attractiveness Analysis

9. South Asia & Oceania Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Grade
- 9.2.4. By Application
- 9.2.5. By Expression Host System
- 9.2.6. By Mode of Action
- 9.2.7. By Species Origin
- 9.2.8. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
- 9.4.1. Transforming Growth Factors (TGF)
  - 9.4.1.1. Activin
  - 9.4.1.2. Bone Morphogenetic Proteins (BMPs)
  - 9.4.1.3. TGF-beta Proteins
- 9.4.2. Epidermal Growth Factors (EGFs)
- 9.4.3. Platelet-Derived Growth Factors (PDGFs)
- 9.4.4. Fibroblast Growth Factors (FGFs)
- 9.4.5. Insulin-like Growth Factors (IGFs)
- 9.4.6. Vascular Endothelial Growth Factors (VEGFs)
- 9.4.7. Hepatocyte Growth Factors (HGFs)
- 9.4.8. Tumor Necrosis Factors (TNFs)
- 9.4.9. Interleukins
- 9.4.10. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
- 9.5.1. GMP Grade
- 9.5.2. NON-GMP Grade
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 9.6.1. Oncology
- 9.6.2. Hematology
- 9.6.3. Wound Healing
- 9.6.4. Dermatology
- 9.6.5. Cardiovascular Disease & Diabetes
- 9.6.6. Cell Therapy & EX-vivo Manufacturing
- 9.6.7. Others
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
- 9.7.1. Animal-Derived Growth Factors
- 9.7.2. Recombinant Growth Factors
9.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
- 9.8.1. Angiogenic Growth Factors
- 9.8.2. Anti-Apoptotic Growth Factors
- 9.8.3. Mitogenic Growth Factors
9.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
- 9.9.1. Human
- 9.9.2. Pig
- 9.9.3. Mouse
- 9.9.4. Rat
- 9.9.5. Others
9.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 9.10.1. Pharmaceutical and Biotechnology Companies
- 9.10.2. Research Centers & Academic Institutes
- 9.10.3. Contract Research Organizations
9.11. Market Attractiveness Analysis

10. Latin America Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Grade
- 10.2.4. By Application
- 10.2.5. By Expression Host System
- 10.2.6. By Mode of Action
- 10.2.7. By Species Origin
- 10.2.8. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
- 10.4.1. Transforming Growth Factors (TGF)
  - 10.4.1.1. Activin
  - 10.4.1.2. Bone Morphogenetic Proteins (BMPs)
  - 10.4.1.3. TGF-beta Proteins
- 10.4.2. Epidermal Growth Factors (EGFs)
- 10.4.3. Platelet-Derived Growth Factors (PDGFs)
- 10.4.4. Fibroblast Growth Factors (FGFs)
- 10.4.5. Insulin-like Growth Factors (IGFs)
- 10.4.6. Vascular Endothelial Growth Factors (VEGFs)
- 10.4.7. Hepatocyte Growth Factors (HGFs)
- 10.4.8. Tumor Necrosis Factors (TNFs)
- 10.4.9. Interleukins
- 10.4.10. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
- 10.5.1. GMP Grade
- 10.5.2. NON-GMP Grade
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 10.6.1. Oncology
- 10.6.2. Hematology
- 10.6.3. Wound Healing
- 10.6.4. Dermatology
- 10.6.5. Cardiovascular Disease & Diabetes
- 10.6.6. Cell Therapy & EX-vivo Manufacturing
- 10.6.7. Others
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
- 10.7.1. Animal-Derived Growth Factors
- 10.7.2. Recombinant Growth Factors
10.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
- 10.8.1. Angiogenic Growth Factors
- 10.8.2. Anti-Apoptotic Growth Factors
- 10.8.3. Mitogenic Growth Factors
10.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
- 10.9.1. Human
- 10.9.2. Pig
- 10.9.3. Mouse
- 10.9.4. Rat
- 10.9.5. Others
10.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 10.10.1. Pharmaceutical and Biotechnology Companies
- 10.10.2. Research Centers & Academic Institutes
- 10.10.3. Contract Research Organizations
10.11. Market Attractiveness Analysis

11. Middle East & Africa Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Grade
- 11.2.4. By Application
- 11.2.5. By Expression Host System
- 11.2.6. By Mode of Action
- 11.2.7. By Species Origin
- 11.2.8. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
- 11.4.1. Transforming Growth Factors (TGF)
  - 11.4.1.1. Activin
  - 11.4.1.2. Bone Morphogenetic Proteins (BMPs)
  - 11.4.1.3. TGF-beta Proteins
- 11.4.2. Epidermal Growth Factors (EGFs)
- 11.4.3. Platelet-Derived Growth Factors (PDGFs)
- 11.4.4. Fibroblast Growth Factors (FGFs)
- 11.4.5. Insulin-like Growth Factors (IGFs)
- 11.4.6. Vascular Endothelial Growth Factors (VEGFs)
- 11.4.7. Hepatocyte Growth Factors (HGFs)
- 11.4.8. Tumor Necrosis Factors (TNFs)
- 11.4.9. Interleukins
- 11.4.10. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
- 11.5.1. GMP Grade
- 11.5.2. NON-GMP Grade
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 11.6.1. Oncology
- 11.6.2. Hematology
- 11.6.3. Wound Healing
- 11.6.4. Dermatology
- 11.6.5. Cardiovascular Disease & Diabetes
- 11.6.6. Cell Therapy & EX-vivo Manufacturing
- 11.6.7. Others
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
- 11.7.1. Animal-Derived Growth Factors
- 11.7.2. Recombinant Growth Factors
11.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
- 11.8.1. Angiogenic Growth Factors
- 11.8.2. Anti-Apoptotic Growth Factors
- 11.8.3. Mitogenic Growth Factors
11.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
- 11.9.1. Human
- 11.9.2. Pig
- 11.9.3. Mouse
- 11.9.4. Rat
- 11.9.5. Others
11.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 11.10.1. Pharmaceutical and Biotechnology Companies
- 11.10.2. Research Centers & Academic Institutes
- 11.10.3. Contract Research Organizations
11.11. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2023
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Thermo Fisher Scientific, Inc.
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Merck KGaA
- 12.3.3. Bio-Rad Laboratories, Inc.
- 12.3.4. Lonza Group AG
- 12.3.5. F. Hoffmann-La Roche Ltd.
- 12.3.6. Sartorius CellGenix GmbH
- 12.3.7. Bio-Techne Corporation
- 12.3.8. GenScript
- 12.3.9. Miltenyi Biotec.
- 12.3.10. Abcam PLC
- 12.3.11. Sino Biological Inc.
- 12.3.12. Cell Signaling Technology, Inc.
- 12.3.13. ACROBiosystems
- 12.3.14. Becton, Dickinson, and Company
- 12.3.15. Creative Bioarray
- 12.3.16. Applied Biological Materials (abm) Inc.
- 12.3.17. GE Healthcare
- 12.3.18. Meridian Bioscience Inc.
- 12.3.19. Repligen Corporation
- 12.3.20. Aviva Systems Biology Corporation (GenWay Biotech)
- 12.3.21. Leadgene Biomedical, Inc.
- 12.3.22. Boster Bio
- 12.3.23. Prospec-Tany Technogene Ltd.
- 12.3.24. Proteintech Group, Inc.
- 12.3.25. AJINOMOTO CO.,INC
- 12.3.26. STEMCELL Technologies
- 12.3.27. Akron Biotech
- 12.3.28. PeproTech Inc.

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations